The original grant titled """"""""Nutritional Determinant of Protein Metabolism in Tumor and Host"""""""" has focused on validating an in vivo isotope model for simultaneous measurement of tissue protein synthesis and degradation rates. This work is significant in that it provides quantitative and mechanistic means to study nutritional variables affecting protein metabolism in the tumor and its host. In the first two years of funding, we have demonstrated the applicability of this method in growing tissues as well as in tissues at near-steady state. To validate this method, we have begun to apply flow cytometry in conjunction with bromodeoxyuridine (BrdUrd) labelling to derive estimates of tumor cell-cycle kinetics. Use of this method, together with 14C-leucine infusion, in the TNF-treated tumor-bearing rat model has demonstrated a correlation between cell lysis and enhanced tumor protein degradation rate. Our work represents the first in vivo demonstration of the antitumor mode of action of TNF. Recognizing the importance of the process of protein degradation, we propose to continue this work by developing the application of cell sorting techniques to determine cycle-specific intracellular protein degradation. We will also utilize multiparameter flow cytometric methods to measure correlated cellular DNA, RNA, and protein. Ratios of the these parameters, determined in each cell, will further characterize the regulation of protein metabolism in tumor tissue. These studies will clarify the physiological significance of protein degradation in relation to tumor growth and call cycle kinetics. Application of multiparameter flow cytometry and viable sorting of tumor cells, in conjunction with in vivo BrdUrd pulse labelling and 14C-leucine infusion, will determine the cycle-specificity of TNF action on protein degradation and the physiological significance of this process in relation to the antitumor effect of TNF. Other work completed during the first two years of funding has demonstrated a significant effect of fish-oil feeding on tumor growth retardation associated with a decrease in protein synthesis. We have also shown that dietary fat can modulate the effect of TNF in the tumor-bearing rat fed fish-oil; the predominant effect of TNF under these dietary conditions is reduced tumor protein synthesis rather than enhanced degradation. The above methodologies are also applicable for determining the mechanism of tumor growth retardation by fish-oil. Our proposed continuation plan will test three alternative hypotheses put forth to explain the effect of fish oil feeding. While the decrease in tumor protein synthesis can be related to diminished tumor cell proliferation potential during fish-oil feeding, the proposed experiments will provide a more definitive answer as to the effects of dietary fat on cell-cycle kinetics (proliferation), host natural cytotoxicity (macrophage activity), and tumor cell susceptibility to this host defense mechanism.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
7R01CA045768-07
Application #
2092005
Study Section
Metabolic Pathology Study Section (MEP)
Project Start
1988-07-01
Project End
1995-11-30
Budget Start
1994-09-30
Budget End
1994-11-30
Support Year
7
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Boston Medical Center
Department
Type
DUNS #
005492160
City
Boston
State
MA
Country
United States
Zip Code
02118
Istfan, N W; Person, K S; Holick, M F et al. (2007) 1alpha,25-Dihydroxyvitamin D and fish oil synergistically inhibit G1/S-phase transition in prostate cancer cells. J Steroid Biochem Mol Biol 103:726-30
Istfan, Nawfal W; Chen, Zhi-Yi; Rex, Sybille (2002) Fish oil slows S phase progression and may cause upstream shift of DHFR replication origin ori-beta in CHO cells. Am J Physiol Cell Physiol 283:C1009-24
Rex, Sybille; Kukuruzinska, Maria A; Istfan, Nawfal W (2002) Inhibition of DNA replication by fish oil-treated cytoplasm is counteracted by fish oil-treated nuclear extract. Am J Physiol Cell Physiol 283:C1365-75
Chen, Z Y; Istfan, N W (2001) Docosahexaenoic acid, a major constituent of fish oil diets, prevents activation of cyclin-dependent kinases and S-phase entry by serum stimulation in HT-29 cells. Prostaglandins Leukot Essent Fatty Acids 64:67-73
Chen, Z Y; Istfan, N W (2000) Docosahexaenoic acid is a potent inducer of apoptosis in HT-29 colon cancer cells. Prostaglandins Leukot Essent Fatty Acids 63:301-8
Istfan, N W; Wan, J M; Bistrian, B R et al. (1994) DNA replication time accounts for tumor growth variation induced by dietary fat in a breast carcinoma model. Cancer Lett 86:177-86
Wan, J M; Bistrian, B R; Figoni, M A et al. (1994) Influence of interleukin-2 infusion on cell cycle kinetics in the Walker-256 carcinosarcoma. J Leukoc Biol 55:241-7
Ling, P R; Bistrian, B R; Mendez, B et al. (1994) Effects of systemic infusions of endotoxin, tumor necrosis factor, and interleukin-1 on glucose metabolism in the rat: relationship to endogenous glucose production and peripheral tissue glucose uptake. Metabolism 43:279-84
Wan, J M; Fogt, F; Bistrian, B R et al. (1993) Evaluation of antitumor effect of tumor necrosis factor in terms of protein metabolism and cell cycle kinetics. Am J Physiol 265:C365-74
Ye, S L; Istfan, N W; Driscoll, D F et al. (1992) Tumor and host response to arginine and branched chain amino acid-enriched total parenteral nutrition. A study involving Walker 256 carcinosarcoma-bearing rats. Cancer 69:261-70

Showing the most recent 10 out of 15 publications